EyenovIA Files 2025 Proxy Statement
Ticker: HYPD · Form: DEF 14A · Filed: Dec 23, 2024 · CIK: 1682639
| Field | Detail |
|---|---|
| Company | Eyenovia, INC. (HYPD) |
| Form Type | DEF 14A |
| Filed Date | Dec 23, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 20 min |
| Key Dollar Amounts | $0.0001, $1.00, $0.10, $0.093, $45,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
EYENOVIA proxy statement filed. Vote on directors & auditors for Jan 21, 2025 meeting.
AI Summary
EyenovIA, Inc. filed its definitive proxy statement on December 23, 2024, for its 2025 annual meeting of stockholders scheduled for January 21, 2025. The filing outlines the proposals to be voted on by shareholders, including the election of directors and the ratification of the appointment of its independent registered public accounting firm.
Why It Matters
This filing is crucial for shareholders as it details the company's governance, executive compensation, and the matters they will vote on, directly impacting the company's future direction and management.
Risk Assessment
Risk Level: low — This is a routine proxy filing detailing upcoming shareholder votes and is not indicative of immediate financial risk.
Key Numbers
- 2025 — Annual Meeting Year (The proxy statement is for the company's 2025 annual meeting.)
- January 21 — Meeting Date (The annual meeting is scheduled for January 21, 2025.)
Key Players & Entities
- EYENOVIA, INC. (company) — Registrant
- 2025 (date) — Fiscal Year End
- January 21, 2025 (date) — Annual Meeting Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the upcoming annual meeting of stockholders on January 21, 2025, and to solicit their votes on important matters.
When is the EyenovIA, Inc. annual meeting of stockholders scheduled to take place?
The annual meeting of stockholders is scheduled for January 21, 2025.
Who is the filer of this proxy statement?
The filer is EYENOVIA, INC., as indicated by the 'Registrant' designation.
What are the key items shareholders will vote on?
While not explicitly detailed in this header, typical proxy statements include the election of directors and ratification of the independent registered public accounting firm.
What is the fiscal year end for EyenovIA, Inc.?
The fiscal year end for EyenovIA, Inc. is December 31.
Filing Stats: 4,913 words · 20 min read · ~16 pages · Grade level 11.7 · Accepted 2024-12-23 06:00:56
Key Financial Figures
- $0.0001 — f the Company's common stock, par value $0.0001 per share (the "common stock") for issu
- $1.00 — mmon stock had closed below the minimum $1.00 per share requirement for continued lis
- $0.10 — common stock had a closing bid price of $0.10 or less for 10 consecutive trading days
- $0.093 — common stock as reported on Nasdaq was $0.093 per share. The Board has approved the
- $45,000 — We expect to pay Alliance approximately $45,000 for their services. 5 SECURITY OWNE
Filing Documents
- tm2430844-2_def14a.htm (DEF 14A) — 396KB
- lg_eyenovia-4clr.jpg (GRAPHIC) — 27KB
- px_24eyenovproxy1pg01-bwlr.jpg (GRAPHIC) — 70KB
- px_24eyenovproxy1pg02-bwlr.jpg (GRAPHIC) — 266KB
- 0001104659-24-130974.txt ( ) — 889KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information with respect to the beneficial ownership of our common stock as of December 2, 2024, for (a) our directors, (b) our named executive officers, (c) our executive officers and directors as a group, and (d) each stockholder known to us to beneficially own more than five percent of our common stock. The number of common shares "beneficially owned" by each stockholder is determined under rules issued by the SEC regarding the beneficial ownership of securities. This information is not necessarily indicative of beneficial ownership for any other purpose. Under these rules, beneficial ownership of common stock includes (1) any shares as to which the person or entity has sole or share voting power or investment power and (2) any shares as to which the person or entity has the right to acquire beneficial ownership within 60 days after December 2, 2024, including any shares that could be purchased by the exercise of options or warrants on or within 60 days after December 2, 2024. We deem shares of common stock that may be acquired by an individual or group within 60 days of December 2, 2024, pursuant to the exercise of options or warrants to be outstanding for the purpose of computing the percentage ownership of such individual or group but are not deemed to be outstanding for the purpose of computing the percentage ownership of any other person shown in the table. Each stockholder's percentage ownership is based on 100,425,129 shares of our common stock outstanding as of December 2, 2024 plus the number of shares of common stock that may be acquired by such stockholder upon the exercise of options or warrants that are exercisable on or within 60 days after December 2, 2024. Unless otherwise indicated in footnotes to this table, we believe that the stockholders named in this table have sole voting and investment power with respect to all shares of common stock